MENU
ANEB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Anebulo Pharmaceuticals (ANEB) Ownership - Who owns Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction... Show more
Profile
Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
44.37M
P/E Ratio
N/A
Total Cash
15M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-1.15
Dividend Yield
N/A
Total Cash/Share
0.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANEB
Capitalization
44.4M
P/E Ratio
N/A
Risk (Beta)
-1.15
Dividend Yield
N/A
Total Cash
15M
Total Cash/Share
0.37
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
15M
P/B Ratio
2.97
Cash Flow
N/A
Earnings
-0.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
41.1K
Current Ratio
17.52
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-65.70
Shares Held By Institutions
37.7M
Shares Outstanding - Current
41.1M
Total Liabilities
879K
Total Volume MTD
N/A
Value
N/A
Gain YTD
-35.714
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com